10月19日，Oscar Health盘中上涨5.19%，报33.545美元，成交额997.8万美元。
消息面上，最新机构观点指出，公司更新后的全年指引已反映积极的医疗利用率趋势，意味着11月5日公布三季度业绩时，超预期空间可能较此前收窄。
进一步看，机构将公司今明后年每股收益预期上调至2.00美元、2.30美元和2.80美元，并把目标价由26美元上调至36美元，但维持中性评级。同时，其提示针对大批会员的资格核查若导致退保偏高，或对收入及潜在上行空间形成扰动。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.